1. Home
  2. XRTX vs RIME Comparison

XRTX vs RIME Comparison

Compare XRTX & RIME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • RIME
  • Stock Information
  • Founded
  • XRTX 2011
  • RIME 1982
  • Country
  • XRTX Canada
  • RIME United States
  • Employees
  • XRTX N/A
  • RIME N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • RIME
  • Sector
  • XRTX Health Care
  • RIME
  • Exchange
  • XRTX Nasdaq
  • RIME NYSE
  • Market Cap
  • XRTX 5.0M
  • RIME 4.9M
  • IPO Year
  • XRTX N/A
  • RIME 1994
  • Fundamental
  • Price
  • XRTX $1.82
  • RIME $0.41
  • Analyst Decision
  • XRTX Strong Buy
  • RIME
  • Analyst Count
  • XRTX 1
  • RIME 0
  • Target Price
  • XRTX $14.00
  • RIME N/A
  • AVG Volume (30 Days)
  • XRTX 125.9K
  • RIME 10.6M
  • Earning Date
  • XRTX 11-14-2024
  • RIME 11-19-2024
  • Dividend Yield
  • XRTX N/A
  • RIME N/A
  • EPS Growth
  • XRTX N/A
  • RIME N/A
  • EPS
  • XRTX N/A
  • RIME N/A
  • Revenue
  • XRTX N/A
  • RIME $37,788,657.00
  • Revenue This Year
  • XRTX N/A
  • RIME N/A
  • Revenue Next Year
  • XRTX N/A
  • RIME N/A
  • P/E Ratio
  • XRTX N/A
  • RIME N/A
  • Revenue Growth
  • XRTX N/A
  • RIME 24.99
  • 52 Week Low
  • XRTX $1.09
  • RIME $0.35
  • 52 Week High
  • XRTX $67.72
  • RIME $1.97
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 53.06
  • RIME N/A
  • Support Level
  • XRTX $1.52
  • RIME N/A
  • Resistance Level
  • XRTX $2.51
  • RIME N/A
  • Average True Range (ATR)
  • XRTX 0.28
  • RIME 0.00
  • MACD
  • XRTX 0.04
  • RIME 0.00
  • Stochastic Oscillator
  • XRTX 31.00
  • RIME 0.00

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About RIME ALGORHYTHM HOLDINGS INC

Algorhythm Holdings Inc is a holding company with two primary investments. It operates through its subsidiaries, one of which is an emerging leader in the AI-enabled global logistics industry. The other subsidiary is engaged in consumer karaoke products, Which designs and distributes the industry's widest assortment of at-home and in-car karaoke entertainment products.

Share on Social Networks: